Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease

References

• Guidetti D, Spallazzi M, Baldereschi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396:1204–1222. doi:10.1016/S0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Celli BR, Singh D, Vogelmeier C, Agusti A. New perspectives on chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;17:2127–2136. doi:10.2147/COPD.S365771
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27. doi:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996;153:530–534. doi:10.1164/ajrccm.153.2.8564092
   PubMed Web of Science ®Google Scholar
• Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41:631–638. doi:10.1165/rcmb.2009-0220TR
   PubMed Web of Science ®Google Scholar
• Henrot P, Prevel R, Berger P, Dupin I. Chemokines in COPD: from implication to therapeutic use. Int J Mol Sci. 2019;21:20. doi:10.3390/ijms21010020
   PubMedGoogle Scholar
• To Y, Ito K, Kizawa Y, et al. Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:897–904. doi:10.1164/rccm.200906-0937OC
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131:636–645. doi:10.1016/j.jaci.2012.12.1564
   PubMed Web of Science ®Google Scholar
• Hakim A, Adcock IM, Usmani OS. Corticosteroid resistance and novel anti-inflammatory therapies in chronic obstructive pulmonary disease: current evidence and future direction. Drugs. 2012;72:1299–1312. doi:10.2165/11634350-000000000-00000
   PubMed Web of Science ®Google Scholar
• Ito K, Lim S, Caramori G, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A. 2002;99:8921–8926. doi:10.1073/pnas.132556899
   PubMed Web of Science ®Google Scholar
• Rossios C, To Y, Osoata G, Ito M, Barnes PJ, Ito K. Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition. Br J Pharmacol. 2012;167:775–786. doi:10.1111/j.1476-5381.2012.01864.x
   PubMed Web of Science ®Google Scholar
• Lewis BW, Ford ML, Rogers LK, Britt RD. Oxidative stress promotes corticosteroid insensitivity in Asthma and COPD. Antioxidants. 2021;10. doi:10.3390/antiox10091335
   Web of Science ®Google Scholar
• Lai T, Tian B, Cao C, et al. HDAC2 Suppresses IL17A-mediated airway remodeling in human and experimental modeling of COPD. Chest. 2018;153:863–875. doi:10.1016/j.chest.2017.10.031
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Casolari P, et al. A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2010;125:1146–1153. doi:10.1016/j.jaci.2010.02.003
   PubMed Web of Science ®Google Scholar
• Liao W, Lim AYH, Tan WSD, Abisheganaden J, Wong WSF. Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease. Br J Pharmacol. 2020;177:3662–3673. doi:10.1111/bph.15080
   PubMed Web of Science ®Google Scholar
• Weng J-Z, Wang Y, Sun T-Y. Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats. Chin Med J. 2019;132:569–576. doi:10.1097/CM9.0000000000000107
   PubMed Web of Science ®Google Scholar
• Sun X-J, Li Z-H, Zhang Y, et al. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-δ/Akt pathway and increasing GR expression. Am J Physiol Lung Cell Mol Physiol. 2015;309:L139–L146. doi:10.1152/ajplung.00292.2014
   PubMed Web of Science ®Google Scholar
• Sun X, Chen L, He Z. PI3K/Akt-Nrf2 and anti-inflammation effect of macrolides in chronic obstructive pulmonary disease. Curr Drug Metab. 2019;20:301–304. doi:10.2174/1389200220666190227224748
   PubMed Web of Science ®Google Scholar
• Li H, Gao C, Liu C, et al. A review of the biological activity and pharmacology of cryptotanshinone, an important active constituent in Danshen. Bio Pharmacot. 2021;137:111332. doi:10.1016/j.biopha.2021.111332
   Google Scholar
• Cha J-D, Lee J-H, Choi KM, Choi S-M, Park JH. Synergistic effect between cryptotanshinone and antibiotics against clinic methicillin and vancomycin-resistant staphylococcus aureus. Evid Based Complement Alternat Med. 2014;2014:450572. doi:10.1155/2014/450572
   PubMed Web of Science ®Google Scholar
• Li -X-X, Zheng X, Liu Z, et al. Cryptotanshinone from Salvia miltiorrhiza Bunge (Danshen) inhibited inflammatory responses via TLR4/MyD88 signaling pathway. Chin Med. 2020;15:20. doi:10.1186/s13020-020-00303-3
   PubMed Web of Science ®Google Scholar
• Jiang Y, You F, Zhu J, Zheng C, Yan R, Zeng J. Cryptotanshinone ameliorates radiation-induced lung injury in rats. Evid Based Complement Alternat Med. 2019;2019:1908416. doi:10.1155/2019/1908416
   PubMed Web of Science ®Google Scholar
• Walters MJ, Paul-Clark MJ, McMaster SK, Ito K, Adcock IM, Mitchell JA. Cigarette smoke activates human monocytes by an oxidant-AP-1 signaling pathway: implications for steroid resistance. Mol Pharmacol. 2005;68:1343–1353. doi:10.1124/mol.105.012591
   PubMed Web of Science ®Google Scholar
• Mitani A, Ito K, Vuppusetty C, Barnes PJ, Mercado N. Restoration of corticosteroid sensitivity in chronic obstructive pulmonary disease by inhibition of mammalian target of rapamycin. Am J Respir Crit Care Med. 2016;193:143–153. doi:10.1164/rccm.201503-0593OC
   PubMed Web of Science ®Google Scholar
• Andelid K, Öst K, Andersson A, et al. Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis. Respir Res. 2021;22:172. doi:10.1186/s12931-021-01762-4
   PubMed Web of Science ®Google Scholar
• Bin Y-F, Ma N, Lu Y-X, et al. Erythromycin reverses cigarette smoke extract-induced corticosteroid insensitivity by inhibition of the JNK/c-Jun pathway. Free Radic Biol Med. 2020;152:494–503. doi:10.1016/j.freeradbiomed.2019.11.020
   PubMed Web of Science ®Google Scholar
• Pinart M, Hussain F, Shirali S, et al. Role of mitogen-activated protein kinase phosphatase-1 in corticosteroid insensitivity of chronic oxidant lung injury. Eur J Pharmacol. 2014;744:108–114. doi:10.1016/j.ejphar.2014.10.003
   PubMed Web of Science ®Google Scholar
• Albano GD, Gagliardo RP, Montalbano AM, Profita M. Overview of the mechanisms of oxidative stress: impact in inflammation of the airway diseases. Antioxidants. 2022;11. doi:10.3390/antiox11112237
   Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• Heijink I, van Oosterhout A, Kliphuis N, et al. Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells. Thorax. 2014;69. doi:10.1136/thoraxjnl-2013-203520
   Web of Science ®Google Scholar
• Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol. 2008;2008:122.
   Google Scholar
• Peveri P, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988;167:1547–1559. doi:10.1084/jem.167.5.1547
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Wada H, Rossios C, et al. A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via phosphoinositide 3-kinase pathway inhibition. Br J Pharmacol. 2013;169:1024–1034. doi:10.1111/bph.12187
   PubMed Web of Science ®Google Scholar
• Sun X-J, Li Z-H, Zhang Y, et al. Theophylline and dexamethasone in combination reduce inflammation and prevent the decrease in HDAC2 expression seen in monocytes exposed to cigarette smoke extract. Exp Ther Med. 2020;19:3425–3431. doi:10.3892/etm.2020.8584
   PubMed Web of Science ®Google Scholar
• Burke JE. Structural basis for regulation of phosphoinositide kinases and their involvement in human disease. Mol Cell. 2018;71:653–673. doi:10.1016/j.molcel.2018.08.005
   PubMed Web of Science ®Google Scholar
• Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med. 2009;179:542–548. doi:10.1164/rccm.200810-1570OC
   PubMed Web of Science ®Google Scholar
• Mercado N, To Y, Ito K, Barnes PJ. Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ. J Pharmacol Exp Ther. 2011;337:465–470. doi:10.1124/jpet.110.175950
   PubMed Web of Science ®Google Scholar
• Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun. 2004;315:240–245. doi:10.1016/j.bbrc.2004.01.046
   PubMed Web of Science ®Google Scholar
• Ngkelo A, Hoffmann RF, Durham AL, et al. Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD. Am J Physiol Lung Cell Mol Physiol. 2015;309:L1112–L1123. doi:10.1152/ajplung.00077.2015
   PubMed Web of Science ®Google Scholar
• Ortiz JL, Milara J, Lluch J, De Diego A, Sanz C, Cortijo J. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress. Allergy. 2013;68:64–73. doi:10.1111/all.12055
   PubMed Web of Science ®Google Scholar
• Li Z, Cheng Q, Yu L, et al. Dan-Lou tablets reduces inflammatory response via suppression of the MyD88/p38 MAPK/NF-κB signaling pathway in RAW 264.7 macrophages induced by ox-LDL. J Ethnopharmacol. 2022;298:115600. doi:10.1016/j.jep.2022.115600
   PubMed Web of Science ®Google Scholar